Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03132675 |
|---|---|
| Brief Title: | Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (Keynote-695) |
| First Submitted : | April 24, 2017 |
| First Submitted that Met QC Criteria : | April 26, 2017 |
| First Posted : | April 28, 2017 |
| Last Update Submitted that Met QC Criteria : | March 24, 2023 |
| Last Update Posted : | March 27, 2023 |